4626:TSETaiyo Holdings Co., Ltd. Analysis
Data as of 2026-06-18 - not real-time
¥5,323.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Taiyo Holdings is trading well above its 20‑day and 50‑day moving averages, with a bullish MACD crossover and a strong positive histogram that underline continued upward momentum. The RSI is comfortably above the 60‑level, indicating robust buying pressure but also hinting at a potential overbought condition. Volume has been on an upward trend, supporting the price advance, while the computed beta is essentially flat, suggesting the stock moves largely independent of broader market swings. However, the discounted cash‑flow fair value sits noticeably below the current market price, and the upside/downside metric points to a modest downside bias. The dividend yield approaches 3% with a payout ratio around 50%, reinforcing the appeal for income‑focused investors. Overall, the technical picture is bullish but the valuation appears stretched, creating a nuanced short‑term outlook.
Fundamentally, the company delivers strong top‑line growth exceeding 20% YoY, solid gross and operating margins, and healthy free cash flow generation that comfortably covers dividend commitments. Return on equity is in the high teens, and the balance sheet shows ample cash despite a moderate debt load. The sector—specialty chemicals—carries medium cyclical risk, while regulatory exposure is moderate given the diverse product mix. Geographic concentration in Japan limits foreign‑exchange volatility, and the improving trading volume mitigates liquidity concerns. These fundamentals, combined with a sustainable dividend, support a more optimistic medium‑ to long‑term perspective.
Fundamentally, the company delivers strong top‑line growth exceeding 20% YoY, solid gross and operating margins, and healthy free cash flow generation that comfortably covers dividend commitments. Return on equity is in the high teens, and the balance sheet shows ample cash despite a moderate debt load. The sector—specialty chemicals—carries medium cyclical risk, while regulatory exposure is moderate given the diverse product mix. Geographic concentration in Japan limits foreign‑exchange volatility, and the improving trading volume mitigates liquidity concerns. These fundamentals, combined with a sustainable dividend, support a more optimistic medium‑ to long‑term perspective.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume support near‑term strength
- RSI in overbought territory raises caution
- Current price above DCF fair value limits upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue growth and expanding margins
- Sustainable dividend yield with comfortable payout ratio
- Improving cash flow generation offsets valuation premium
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Diversified product portfolio across chemicals, pharmaceuticals, and renewable energy
- Consistent free cash flow enabling reinvestment and dividend stability
- Potential valuation re‑rating as market aligns price with intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth20.40%
Profit Margin17.42%
P/E Ratio32.3
ROE21.95%
ROA10.26%
Debt/Equity49.11
P/B Ratio5.1
Op. Cash Flow¥30.7B
Free Cash Flow¥18.2B
Technical Analysis
TrendBullish
RSI67.7
Support¥4,833.00
Resistance¥5,508.00
MA 20¥5,057.00
MA 50¥4,912.52
MA 200¥4,682.77
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5
Valuation
Fair Value¥4,885.25
Target Price¥5,000.00
Upside/Downside-6.07%
GradeOvervalued
TypeGrowth
Dividend Yield2.92%
Risk Assessment
Beta-0.01
Volatility20.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.